Doctors and healthcare professionals in the field of sexual health from across the Middle East will gather in Dubai on 8 February to hear from some of the world’s leading sexual medicine experts who will be presenting their latest clinical study findings at the three-day 3rd Biennial Conference of the Pan-Arab Society for Sexual Medicine.
International speakers from the US, UK, Germany, Australia, as well as a few from within the region, will share their perspectives on the contemporary practice of sexual medicine, sharing practical data but also insight into available therapy options.
“The Middle East medical community is fortunate to be able to host such a high-level, scientific event in Dubai. This event will introduce healthcare providers to the many diverse perspectives of contemporary sexual medicine,” said Dr. Tarek Anis, President of the Pan-Arab Society for Sexual Medicine.
Pfizer, makers of erectile dysfunction drug Viagra, will act as sole platinum sponsors of the event.
“Pfizer is proud to play an active role in making possible events like the PASSM in Dubai this year. By sponsoring the event, we are demonstrating our commitment to the ongoing study and safe and effective treatment of sexual conditions,” said Dr. Ahmed El Hakim, Pfizer’s Middle East Director of Health Policy and External Affairs.
Viagra leads the ED market worldwide, as well as in the Middle East region.
Since its launch eight years ago, Viagra has been clinically proven to be a safe and effective ED therapy, with over 130 clinical trials involving over 13,000 men – more than any other impotence drug.
More than 27 million men worldwide have been prescribed Viagra, with over 1.5 billion tablets dispensed. Use among men in the Middle East has increased significantly in the past four years after the establishment of Viagra as a solution for enhancing erectile function with an unsurpassed efficacy and safety record.
About PfizerFor further information go to: www.pfizer.com